USSTC's Modified-Risk Application for Copenhagen Moves Through FDA CommitteeMajority of the agency's TPSAC panel voted scientific evidence supported the proposed claim. Altria Invests in Emerging Opportunities for Long-Term SuccessJuul and Cronos stakes come amid changing tobacco landscape. Higher Wages, Cheaper Gas & Effective Loyalty Programs Make for a Stable Tobacco Consumer Price gaps grow as consumers continue downtrading to fourth-tier cigarettes and vapor products. New York & Virginia Consider Taking Tobacco 21 Statewide N.Y. Gov. Andrew Cuomo also proposes a ban on pharmacy sales and display restrictions. Altria Takes 'Significant Action' to Prepare for Its Future Chairman and CEO Howard Willard says its investment in Juul is the most sustainable opportunity to generate significant income in the e-vapor category. Altria Secures $12.8B Minority Stake in Juul The deal comes just weeks after the tobacco giant discontinued its vapor product lines. Altria Makes $1.8B Investment in Canadian Cannabis Market The deal for a 45-percent stake in Cronos Group Inc. is expected to close in the first half of 2019. Altria Shifts Gears on Innovative Products Platform Tobacco leader will discontinue all MarkTen and Green Smoke vapor products, and VERVE oral products. People on the Move: CDA, Getty Realty, Murphy USA & PriceAdvantage Berner Food and Beverage, Ice-O-Matic, NCA, PFSbrands and Talking Rain also make personnel news. Altria Reportedly in Talks to Take a Stake in Juul Wells Fargo Securities estimates the deal could come with a $4-billion to $7-billion price tag. First Previous 12 13 14 15 16 Next Last
